Exubrion Therapeutics Logo Registered

a quantum
leap forward
in canine OA management

At Exubrion Therapeutics®, our vision is to forever improve the compassionate care of companion animals

Our name, Exubrion, emerged from the word “exuberance,” which is the quality of being full of energy and excitement.

  • “Exubrion” speaks to our determination to help animals live healthy, active, and pain-free lives.
  • “Exubrion” also identifies our enthusiasm for supporting those veterinarians who care for pets by providing new, innovative therapies, specifically for relieving the pain and suffering of canine osteoarthritis (OA).

Meet our seasoned leadership team with experts in animal health and nuclear medicine.

We understand the debilitating nature of OA and strive to help families to continue sharing joyful interaction with their ‘best friends’ through the application of groundbreaking, science-based solutions which:1,2

  • Reduce pain and inflammation
  • Break the vicious inflammatory cycle of degenerative joint disease
  • Help restore the active lives of companion animals

Watch our leadership team talk about how we’re making huge strides to improve the lives of dogs with OA.

Our goal is to ensure both veterinarians and pet parents have an effective option to alleviate OA pain and inflammation

Icon Molecule

Utilizes innovative, breakthrough technology

Icon Clipboard

Addresses one of the most significant areas of unmet need in veterinary medicine

icon dog

Provides a solution specifically developed and extensively studied for use in dogs

At Exubrion Therapeutics®, we are harnessing the power of conversion electron therapy from Tin-117m

We see Tin-117m as a platform therapy with the potential to treat not only arthritis but also other medical conditions in a variety of species.

Our proprietary conversion electron therapy—Tin-117m

  • The potential to give animals with OA an improved quality of life1
  • An opportunity to improve the current treatment options for the progressive and debilitating disease of OA1

Our initial product, Synovetin OA®—for canine elbow OA

  • The ability to intervene in the inflammation/pain cycle, of OA2
  • The treatment confidence of 1 minimally invasive intra-articular injection that delivers up to 1 full year of response1
Synovetin OA logo

We are driven to help pets, their families, and their veterinarians

Dog jumping for ball

Our commitment to pets

Do more for dogs with unresolved pain to help improve their ability to run, jump, and play.

Hugging dog

Our commitment to pet parents

Help people better care for beloved canine family members without the need for daily medications, multiple injections, or lengthy rehabilitation.


Our commitment to veterinarians

Support surgeons in more confidently alleviating the chronic pain of OA and improving the active lives of dogs.


  1. Data on File, Exubrion Therapeutics®.
  2. Fox SM, Donecker JM. Synovitis Technical Bulletin. Exubrion Therapeutics, Inc. July 2019.